Cómo contactar con el centro
Centro HCP
AMC / LUMC actúan como centros de conocimiento en temas de salud pública con impacto en la sociedad, tienen una función directiva en la región y actúan como centros de educación continua y formación continua para profesionales médicos.
AMC/LUMC son centros especializados en enfermedades oculares raras, con una activa investigación clínica y básica sobre este tema. La base de datos oftalmogenéticos de AMC es una de las más grandes del mundo.
Imagen: Steven Lek
Contacto
Amsterdam University Medical Center / Leiden University Medical Center
Equipo
Pr Camiel BOON
Netherlands
Dr Axel PETZOLD
Netherlands
Los ensayos clínicos
NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Half-dose photodynamic therapy versus eplerenone treatment in chronic centralserous chorioretinopathy.
Natural history of the progression of X-linked retinitis pigmentosa.
Prospective Clinical Trial to Evaluate the Efficacy of Acetazolamide for the Treatment of Cystoid Fluid Collections in Retinoschisis: The AXIS Trial
A multi-national, multi-centre, double-masked, placebo-controlled proof of concept trial to evaluate the safety and efficacy of oral soraprazan in Stargardt disease
Development of Novel Clinical Endpoints for Interventional Clinical Trials With a Regulatory and Patient Access Intention in Patients With Intermediate Age-related Macular Degeneration (AMD)